Synergistic Combination of Tamoxifen–Tetraphenylethylene Co‐Assembled Micelles and Orlistat‐Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202502060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Jung Yeon Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea. Hauptthemen laut MEDLINE: Tamoxifen, Orlistat, Micelles, Lipid Droplets. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, MSIT, KIST Institutional Program.
Abstract (Originalsprache)
Nanostructured supramolecular materials enable the precise control of biological interactions by tuning structural features such as size, shape, and surface charge, allowing targeted cellular uptake, optimized biodistribution, and enhance therapeutic efficacy. Despite its clinical success, tamoxifen (TMX) therapy faces challenges, such as drug resistance development; a key resistance mechanism involves intracellular lipid alterations. Lipid droplets (LD) play a crucial role in cancer progression and resistance to therapy. However, the direct suppression of LD formation as a synergistic adjunct to enhance TMX delivery remains underexplored. In this study, a supramolecular micelle platform based on amphiphilic tetraphenylethylene derivatives are presented with tunable oligoethylene glycol (OEG) side‐chain lengths. By modulating the OEG length, micelles with distinct surface charges are developed that significantly improve intracellular the TMX delivery to LDs. Furthermore, this system enabled visualization of intracellular drug distribution via intrinsic fluorescence. This targeted delivery reveales that LD‐mediated TMX sequestration is a resistance mechanism in estrogen receptor‐positive breast cancer. Importantly, co‐treatment with orlistat, an LD formation inhibitor, disrupted this resistance pathway and markedly enhance TMX efficacy of TMX. This dual‐functional approach, combining organelle‐specific delivery and LD modulation, constitutes a powerful supramolecular strategy to overcome TMX resistance and advances the development of next‐generation cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
- Biomedical Research Division, Medicinal Materials Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
- Department of HY-KIST Bio-convergence, Hanyang University, Seoul, 04763, Republic of Korea.
- Beamline division, Pohang Accelerator Laboratory, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea.
- KHU-KIST Department of Converging Science and Technology, Hanyang University, Seoul, 02453, Republic of Korea.
- Department of Integrative Energy Engineering, Korea University, Seoul, 02841, Republic of Korea.
ORCID-Profile: Yongju Kim
Förderung
- National Research Foundation of Korea
- MSIT
- KIST Institutional Program
Zitieren
APA
Park, J. Y., Lee, J., Kim, Y. Y., Lee, S., & Kim, Y. (2025). Synergistic Combination of Tamoxifen–Tetraphenylethylene Co‐Assembled Micelles and Orlistat‐Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502060
Vancouver
Park JY, Lee J, Kim YY, Lee S, Kim Y. Synergistic Combination of Tamoxifen–Tetraphenylethylene Co‐Assembled Micelles and Orlistat‐Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202502060
BibTeX
@article{Park2025,
author = {Park, Jung Yeon and Lee, Jeehee and Kim, Young Yong and Lee, Sanghee and Kim, Yongju},
title = {Synergistic Combination of Tamoxifen–Tetraphenylethylene Co‐Assembled Micelles and Orlistat‐Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202502060}
}
EUVIMED